Search Results - "Stulak, J."

Refine Results
  1. 1

    Impact of Gastrointestinal Bleeding Burden with Subsequent Outcomes after Left Ventricular Assist Device Implant by Schettle, S., Shanin, Y., Schirger, J., Pahwa, S., Weber, M., Tchantchaleishvili, V., Stulak, J.

    “…Gastrointestinal bleeding (GIB) is a frequent post left ventricular assist device (LVAD) co-morbidity, and many patients require multiple endoscopic…”
    Get full text
    Journal Article
  2. 2

    Intrinsic Myocardial Function and Relationship with Left Ventricular Unloading in Patients Supported on CF-LVAD Therapy by Rosenbaum, A.N., Soldatova, A., Stulak, J.M., Clavell, A., Behfar, A.

    “…Despite strong interest in left ventricular recovery, no clinical data exist on the relationship between intrinsic myocardial function and reverse remodeling…”
    Get full text
    Journal Article
  3. 3

    Heart Failure Duration Association with Gastrointestinal Bleeding Post Left Ventricular Assist Device by Schettle, S., Shahin, Y., Rosenbaum, A., Schirger, J., Weber, M., Tchantchaleishvili, V., Stulak, J.

    “…Gastrointestinal bleeding (GIB) is a frequent post left ventricular assist device (LVAD) co-morbidity with gastrointestinal angiodysplasia (GIAD) commonly…”
    Get full text
    Journal Article
  4. 4

    Outcomes Following Discontinuation of Warfarin in Heartmate 3 Patients: A Multi-Center Review by Schettle, S., Stulak, J., Rosenbaum, A., Cheyne, C., Ayers, B., Alexis, J., Gosev, I.

    “…Bleeding complications during left ventricular assist device (LVAD) support pose anticoagulation challenges as risk of discontinuation of anticoagulation, even…”
    Get full text
    Journal Article
  5. 5

    The Fallout of Heart Allocation System Changes: Practice Patterns and Landscape of the Recipient by Schumer, E.M., Khullar, V., Daly, R.C., Behfar, A., Stulak, J.M.

    “…The United Network for Organ Sharing (UNOS) implemented a new heart allocation system on October 1, 2018. This has inevitably changed the strategy to position…”
    Get full text
    Journal Article
  6. 6

    The Impact of the New Heart Allocation System: Is Donor-Recipient Mismatch Still Clinically Important? by Schumer, E.M., Khullar, V., Daly, R.C., Behfar, A., Stulak, J.M.

    “…The heart allocation system underwent major changes 1 year ago and the clinical impact is yet to be fully analyzed. We sought to examine clinical…”
    Get full text
    Journal Article
  7. 7

    Computational Sentiment Analysis of LVAD Support Group: Positivity Predominates by Austin, M.A., Saxena, A., Ott, N., O'Malley, T.J., Maynes, E.J., Massey, H.T., Loforte, A., Stulak, J.M., Tchantchaleishvili, V.

    “…Despite well-documented left ventricular assist device (LVAD) complications, the impact of these complications on the individual patient, as well as the…”
    Get full text
    Journal Article
  8. 8

    Functional Outcomes Not Significantly Impacted by Hemocompatibility-Related Adverse Event Burden among Different Devices by Pahwa, S., Lee, G., Tchantchaleishvili, V., Weber, M., Khullar, V., Daly, R., Schumer, E., Rosenbaum, A., Schettle, S., Behfar, A., Stulak, J.

    “…Landmark work has demonstrated that the hemocompatibility-related adverse event (HRAE) burden is significantly lower with the newest centrifugal flow pump;…”
    Get full text
    Journal Article
  9. 9

    Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients without Antiplatelet Therapy by Jorde, U., Katz, J.N., Colombo, P.C., Stulak, J.M., Crandall, D., Franke, A., Adamson, R.M.

    “…Optimization of antithrombotic therapy, with the goal of minimizing bleeding without adversely affecting thromboembolic (TE) rates, is a major priority of the…”
    Get full text
    Journal Article
  10. 10

    Pilot Studies towards Optimizing Quality of Life and Outcomes in Patients Post Left Ventricular Assist Device Implantation by Sajgalik, P., Kim, C., Wheatley-Guy, C., Clavell, A.L., Kushwaha, S.S., Stulak, J.M., Schettle, S.D., Cierzan, B.S., Schirger, J.A., Johnson, B.D.

    “…For optimization of the pump setting, there is currently a lack of non-invasive diagnostic methods capable to sensitively reflect the altered right-to-left…”
    Get full text
    Journal Article
  11. 11

    Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation by Asleh, R., Briasoulis, A., Smith, B., Lopez, C., Lerman, A., Pereira, N.L., Daly, R.C., Kremers, W.K., Clavell, A.L., Stulak, J.M., Kushwaha, S.S.

    “…Enhanced platelet reactivity may play a role in the development and progression of cardiac allograft vasculopathy (CAV). Although aspirin is often a part of…”
    Get full text
    Journal Article
  12. 12

    Combined Heart-Kidney Transplantation: Vasoplegia is Associated with Poorer Post-Kidney Transplant Outcomes by Steadman, J.A., Stulak, J.M., Clavell, A.L., Kushwaha, S.S., Edwards, B.S., Pereira, N.L., Dunlay, S.M., Schirger, J.A., Frantz, R.P., Smith, B.H., Dean, P.G., Daly, R.C.

    “…Candidate selection for multi-organ transplants should consider the chances of good function and benefit of all transplanted organs. Risk factors for early…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20